Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
24,000.00
(
1.06%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
98.30
(
-2.89%
)
Bitcoin
74,829.43
(
2.78%
)
News Focus
News Focus
Post# of 257249
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 93823

Thursday, 04/08/2010 1:46:13 PM

Thursday, April 08, 2010 1:46:13 PM

Post# of 257249
Brazil is phasing out the use of similares, which are knockoffs of branded drugs that have not demonstrated bioequivalence to the corresponding brand. When similares are gone, the generic-drug market in Brazil will be a lot like the one in the US.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now